Effects of exercise on circulating tumor cells among patients with resected stage I-III colon cancer

被引:27
|
作者
Brown, Justin C. [1 ]
Rhim, Andrew D. [2 ]
Manning, Sara L. [3 ]
Brennan, Luke [3 ]
Mansour, Alexandra I. [3 ]
Rustgi, Anil K. [4 ]
Damjanov, Nevena [4 ]
Troxel, Andrea B. [5 ]
Rickels, Michael R. [4 ]
Ky, Bonnie [4 ]
Zemel, Babette S. [4 ,6 ]
Courneya, Kerry S. [7 ]
Schmitz, Kathryn H. [8 ]
机构
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Univ Michigan, Med Sch, Ann Arbor, MI 48109 USA
[4] Univ Penn, Philadelphia, PA 19104 USA
[5] NYU, New York, NY USA
[6] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[7] Univ Alberta, Edmonton, AB, Canada
[8] Penn State Coll Med, Hershey, PA USA
来源
PLOS ONE | 2018年 / 13卷 / 10期
基金
美国国家卫生研究院;
关键词
SURROGATE END-POINTS; COLORECTAL-CANCER; PHYSICAL-ACTIVITY; INSULIN-RESISTANCE; GROWTH-FACTOR; SHEAR-STRESS; BLOOD-FLOW; MORTALITY; SURVIVORS; OBESITY;
D O I
10.1371/journal.pone.0204875
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Physical activity is associated with a lower risk of disease recurrence among colon cancer patients. Circulating tumor cells (CTC) are prognostic of disease recurrence among stage I-III colon cancer patients. The pathways through which physical activity may alter disease outcomes are unknown, but may be mediated by changes in CTCs. Methods Participants included 23 stage I-III colon cancer patients randomized into one of three groups: usual-care control, 150 min-wk-1 of aerobic exercise (low-dose), and 300 min-wk-1 of aerobic exercise (high-dose) for six months. CTCs from venous blood were quantified in a blinded fashion using an established microfluidic antibody-mediated capture device. Poisson regression models estimated the logarithmic counts of CTCs. Results At baseline, 78% (18/23) of patients had >= 1 CTC. At baseline, older age (-0.12+/- 0.06; P=0.04), lymphovascular invasion (0.63+/-0.25; P=0.012), moderate/poor histology (1.09 +/-0.34; P=0.001), body mass index (0.07+/-0.02; P=0.001), visceral adipose tissue (0.08 +/-0.04; P=0.036), insulin (0.06+/-0.02; P=0.011), sICAM-1 (0.04+/-0.02; P=0.037), and sVCAM-1 (0.06+/-0.03; P=0.045) were associated with CTCs. Over six months, significant decreases in CTCs were observed in the low-dose (-1.34+/-0.34; P<0.001) and high-dose (-1.18+/-0.40; P=0.004) exercise groups, whereas no significant change was observed in the control group (-0.59+/-0.56; P=0.292). Over six months, reductions in body mass index (-0.07+/-0.02; P=0.007), insulin (-0.08+/-0.03; P=0.014), and sICAM-1 (-0.07+/-0.03; P=0.005) were associated with reductions in CTCs. The main limitations of this proof-of-concept study are the small sample size, heterogenous population, and per-protocol statistical analysis. Conclusion Exercise may reduce CTCs among stage I-III colon cancer patients. Changes in host factors correlated with changes in CTCs. Exercise may have a direct effect on CTCs and indirect effects through alterations in host factors. This hypothesis-generating observation derived from a small pilot study warrants further investigation and replication.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] A robust gene signature for the detection of early relapse in stage I-III colon cancer
    Dai, W.
    Li, Y.
    Li, Q.
    Cai, G.
    ANNALS OF ONCOLOGY, 2017, 28
  • [32] A robust gene signature for the prediction of early relapse in stage I-III colon cancer
    Dai, Weixing
    Li, Yaqi
    Mo, Shaobo
    Feng, Yang
    Zhang, Long
    Xu, Ye
    Li, Qingguo
    Cai, Guoxiang
    MOLECULAR ONCOLOGY, 2018, 12 (04) : 463 - 475
  • [33] A robust gene signature for the detection of early relapse in stage I-III colon cancer
    Dai, W.
    Li, Y.
    Mo, S.
    Cai, G.
    ANNALS OF ONCOLOGY, 2017, 28
  • [34] Comparison of survival of stage I-III colon cancer by travel distance and hospital volume
    Turner, M. C.
    Jawitz, O.
    Adam, M. A.
    Srinivasan, E.
    Niedzwiecki, D.
    Migaly, J.
    Fisher, D. A.
    Mantyh, C. R.
    TECHNIQUES IN COLOPROCTOLOGY, 2020, 24 (07) : 703 - 710
  • [35] Immune cell infiltration as a biomarker for the diagnosis and prognosis of stage I-III colon cancer
    Zhou, Rui
    Zhang, Jingwen
    Zeng, Dongqiang
    Sun, Huiying
    Rong, Xiaoxiang
    Shi, Min
    Bin, Jianping
    Liao, Yulin
    Liao, Wangjun
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2019, 68 (03) : 433 - 442
  • [36] Preoperative serum markers for individual patient prognosis in stage I-III colon cancer
    Giessen-Jung, Clemens
    Nagel, Dorothea
    Glas, Maria
    Spelsberg, Fritz
    Lau-Werner, Ulla
    Modest, Dominik Paul
    Schulz, Christoph
    Heinemann, Volker
    Di Gioia, Dorit
    Stieber, Petra
    TUMOR BIOLOGY, 2015, 36 (10) : 7897 - 7906
  • [37] Surgical treatment experience for patients with stage I-III esophageal cancer
    Kolesnik, O. P.
    Kolesnyk, I. P.
    Kechedzhyiev, V. V.
    ZAPOROZHYE MEDICAL JOURNAL, 2018, (03) : 448 - 453
  • [38] Development and validation of postoperative circulating tumor DNA combined with clinicopathological risk factors for recurrence prediction in patients with stage I-III colorectal cancer
    Zhaoya Gao
    Dandan Huang
    Hui Chen
    Yong Yang
    Ke An
    Changmin Ding
    Zheping Yuan
    Zhichao Zhai
    Pengfei Niu
    Qingkun Gao
    Jinping Cai
    Qingmin Zeng
    Yanzhao Wang
    Yuming Hong
    Wanshui Rong
    Wensheng Huang
    Fuming Lei
    Xiaodong Wang
    Shiqing Chen
    Xiaochen Zhao
    Yuezong Bai
    Jin Gu
    Journal of Translational Medicine, 21
  • [39] Clinical characteristics and prognosis analysis of postoperative patients with stage I-III colon cancer based on SEER database
    Zhao, Fuqiang
    Sun, Ying
    Zhao, Jingying
    Ge, Jie
    Zheng, Chunlei
    Ning, Kepeng
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (01): : 225 - 230
  • [40] Development and validation of postoperative circulating tumor DNA combined with clinicopathological risk factors for recurrence prediction in patients with stage I-III colorectal cancer
    Gao, Zhaoya
    Huang, Dandan
    Chen, Hui
    Yang, Yong
    An, Ke
    Ding, Changmin
    Yuan, Zheping
    Zhai, Zhichao
    Niu, Pengfei
    Gao, Qingkun
    Cai, Jinping
    Zeng, Qingmin
    Wang, Yanzhao
    Hong, Yuming
    Rong, Wanshui
    Huang, Wensheng
    Lei, Fuming
    Wang, Xiaodong
    Chen, Shiqing
    Zhao, Xiaochen
    Bai, Yuezong
    Gu, Jin
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)